QuidelOrtho Corporation's 2023 operating cash flow estimate missed significantly. Read why I'm neutral on QDEL stock.

Shares of QuidelOrtho Co. (NASDAQ:QDEL – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat.com reports ...

QuidelOrtho Corporation (NASDAQ:QDEL), a prominent player in the Life Science Tools, Diagnostics, and MedTech sectors with a market capitalization of $2.7 billion, has been navigating a complex market ...

QuidelOrtho (NASDAQ:QDEL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” ...

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and ...